Cokorda Istri Mas Dalem Sukawati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cokorda Istri Mas Dalem Sukawati has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Agustinus I Wayan Harimawan
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
1 shared publication - Anak Agung Sagung Mirah Prabandari
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
1 shared publication - I Wayan Gede Sutadarma
Department of Clinical Nutrition, Faculty of Medicine, Udayana University
1 shared publication - I Wayan Weta
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
1 shared publication - Ni Ketut Sumartini
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
1 shared publication - Syuma Adhy Awan
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
1 shared publication
Latest Publications
- Open Access
- 8 November 2026
- Published by Politeknik Kesehatan Kemenkes Aceh in Jurnal SAGO Gizi dan Kesehatan
- Vol. 7 (3) , 862-873
The effect of glutamine supplementation on mortality, length of hospital stay, and systemic infections in burn patients: A systematic review and meta-analysis of randomized controlled trials
Background: The clinical benefits of glutamine supplementation in patients with burn injuries remain uncertain. Although glutamine has been proposed to support immune function and recovery, its effects on major clinical outcomes are inconsistent.Objectives: This systematic review and meta-analysis evaluated the effects of glutamine supplementation on hospital length of stay, all-cause mortality, and systemic infectious complications in patients with burn injuries.Methods: PubMed/MEDLINE, Scopus, and the Cochrane Library were searched through July 26, 2026, for randomized controlled trials comparing glutamine supplementation with placebo or standard care. The review was registered in PROSPERO (CRD420261461723). Pooled estimates were calculated using random-effects models.Results: Eleven randomized controlled trials involving 1,662 participants were included. No statistically significant reductions were detected in hospital length of stay (mean difference, −3.22 days; 95% CI, −7.62 to 1.19), all-cause mortality (odds ratio, 0.92; 95% CI, 0.69–1.23), or systemic infectious complications (odds ratio, 0.97; 95% CI, 0.75–1.25). Heterogeneity was substantial for hospital length of stay (I² = 89%).Conclusions: The pooled findings did not demonstrate a clear benefit of routine glutamine supplementation for these outcomes in patients with burn injuries. Interpretation remains limited by heterogeneity and uncertainty in the included evidence.
- 8 November 2026
- Published by Politeknik Kesehatan Kemenkes Aceh in Jurnal SAGO Gizi dan Kesehatan
- Vol. 7 (3) , 862-873
Open AccessThe effect of glutamine supplementation on mortality, length of hospital stay, and systemic infections in burn patients: A systematic review and meta-analysis of randomized controlled trials
Background: The clinical benefits of glutamine supplementation in patients with burn injuries remain uncertain. Although glutamine has been proposed to support immune function and recovery, its effects on major clinical outcomes are inconsistent.Objectives: This systematic review and meta-analysis evaluated the effects of glutamine supplementation on hospital length of stay, all-cause mortality, and systemic infectious complications in patients with burn injuries.Methods: PubMed/MEDLINE, Scopus, and the Cochrane Library were searched through July 26, 2026, for randomized controlled trials comparing glutamine supplementation with placebo or standard care. The review was registered in PROSPERO (CRD420261461723). Pooled estimates were calculated using random-effects models.Results: Eleven randomized controlled trials involving 1,662 participants were included. No statistically significant reductions were detected in hospital length of stay (mean difference, −3.22 days; 95% CI, −7.62 to 1.19), all-cause mortality (odds ratio, 0.92; 95% CI, 0.69–1.23), or systemic infectious complications (odds ratio, 0.97; 95% CI, 0.75–1.25). Heterogeneity was substantial for hospital length of stay (I² = 89%).Conclusions: The pooled findings did not demonstrate a clear benefit of routine glutamine supplementation for these outcomes in patients with burn injuries. Interpretation remains limited by heterogeneity and uncertainty in the included evidence.